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Heterotrimerlc GTP-binding proteins transduce receptor-medlated xtracellular signals to their effecters. Several activated mutations of Gscl and 
Gia have been shown to be assoctated with endocrme tumors. In thts report. we have evaluated the transforming activity of an putative activated 
form of Gal2 subunit. We found that transient expresston in NlH3T3 cells of the Gal2 mutant with substitution of glutamine- for leucine could 
lead to focus formation and that stably transfected NlH3T3 cells could form colonies in soft agar and tumors m nude mice 
G protein, Transformation; Mutatton 
1. INTRODUCTION 
The constitutive activation of key elements in a vari- 
ety of signaling systems can lead to oncogenesis. Thus, 
for example, mutations in the YUS gene that stabilize it 
in its GTP-bound form have been associated with a 
wide variety of tumors, and there is good evidence for 
a causal role of these mutations in oncogenesis [I]. 
Other mutations leading to constitutively signaling re- 
ceptors or to the activation of other components of this 
pathway such as the Raf serine-threonine kinase have 
also been shown to be oncogenic [2]. In addition. there 
are a variety of reports that constitutive signaling 
through other pathways can lead to oncogenesis, thus, 
for example. mutation or overproduction of G-Protein 
Couple receptor proteins has been shown to be onco- 
genie [3-51 and there are specific examples of activated 
forms of the heterotrimeric GTP binding protein that 
act as signal transducers in this pathway such as the Gscl 
and Gia: proteins that appear to be associated with 
human endocrine tumors [6,7]. There are at least 16 
different genes that encode Ga subunits in mammalian 
systems. They can be arranged into four families on the 
basis of their amino acid sequence similarities Gs. Gi, 
Gq, and G12 [8]. It is not clear that activating mutations 
in each of the different GTP binding Gcr subunits can 
lead to neoplastic transformation. Thus, for example, 
while a mutant of the c( mutant of Gi2 was found to 
induce transformation in Rat1 cells, it was not very 
effective in NIH3T3 cells [9911]. There are also various 
different reports about the activity of the Cq class of 
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Abbrerkmons. G protein: GTP-binding protein, PCR. polymerase 
cham reactton: FCS. fetal calf serum. 
GTP binding alpha subunit proteins. While some 
groups have found that activated forms of Caq are 
associated with transformation [12,13], we have found 
that activation of Gclq leads primarily to cell death [14]. 
Surviving cells may be tumorigenic, however, it is not 
clear whether the Gcrq protein acts to select oncogenic 
cells or if it is involved directly, i.e. as a causal agent in 
the transformation event. Recently, using an expression 
cloning technique, it has been found that the overex- 
pression of Gal2 in NIH3T3 cells leads to transforma- 
tion [ 151. In order to further test the oncogenic activity 
of Gal’, we have prepared an activated mutation in 
Gal2 cDNA and expressed the cDNA using the CMV 
promoter. Our results suggest that the activated muta- 
tion can efficiently transform NIH3T3 cells and a large 
fraction of the stable transformed cells can lead to the 
formation of colonies in soft agar and tumorigenesis in 
nude mice. 
2. MATERIALS AND METHODS 
2. I Con.~trucrrott of esprrs~ton p1u.rntttl.s of Gal-7 und GalZQL 
cDNA encoding Gal2 or Gal2QL was carried by a pCMV vector 
[14]. whtch has a human cytomegaloviral promoter and enhancer. The 
putative GTPase-defictent mutant GalZQL with substitutton of glu- 
tamine-229 for leucme was made by site-dnected mutagenests wtth 
PCR [I 61 and mutattons were vertfied by DNA sequencing. 
NIH3T3 cells (American Type Culture Collection) were maintained 
m Dulbecco’s modified Eagle’s medium containing 10% fetal calf 
serum (FCS). For focus-forming assay, cells were seeded mto 10 cm 
dishes at a density of 5 x IO” the day before transfectton Expression 
plasmtd DNAs (20 pg per dish) were introduced mto cells with the 
calcium phosphate prectpitatton method by using a Stratagene trans- 
fectton kit. Foci were vtsualized by staming with Methylene blue 10 
days after transfectton For stable transfectton. cells were transfected 
in the same way as in the focus-formmg assay. except that 2 lg of 
PGKneo were added to provtde antibiotic selection. The stably trans- 
fected cell lmcs were selected with 250,ug/ml of active geneticin (BRL). 
2 3. Growth assay and tun~origenesis m nude mrc’r 
To construct growth curves for stably transfected cell lutes, cells 
were seeded in each well of 24-well plates at a density of 2 x 10”. The 
numbers of cells were counted every other day. For the growth assay 
m low concentration of FCS, cells were seeded in DMEM contaming 
10% FCS and then changed into medium contaming 0.1% FCS after 
5 h. One hundred and fifty cells were seeded for the soft agar assay. 
The numbers of colonies in soft agar containmg more than 20 cells 
were counted after three weeks. 
2.4. Expression of Gal? or Gal2QL in the stab!, trunsficted cdl IUWJ 
Total RNA was isolated from the stably transfected cell lines. After 
reverse transcription cDNA was amplified by using PCR with a pau 
of primers corresponding to nucleotides 80&830 of the Gal2 cDNA 
a 
Volume 330, number 3 FEBS LETTERS September 1993 
and to a sequence from the 3’ arm of the pCMV vector. The predicted 
size of the PCR products should be approximately 470 bp for Gall 
and 750 bp for Gal3QL. 
3. RESULTS AND DISCUSSION 
To determine whether Gal 2 plays a role in regulation 
of cell growth. we transiently transfected NIH3T3 cells 
with cDNAs encoding Cal2 and its mutant Gcxl2QL. 
We found that Ga12QL could induce focus formation 
and cells in the foci showed morphology that was char- 
acteristic of transformed cells, even though the sizes of 
I b 
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Fig. 1. Gal2QL-induced focus formation in NIH3T3 cells. NIH3T3 cells were transiently transfected with cDNA encoding vector pCMV (a), Gal2 
(b), Gal2QL (c) and rasQ61 L (d). Ten days later foci were stained with Methylene blue. The morphologies of normal NIH3T3 cells (e) and those 
(f) m a focus from Panel (c) are shown below 
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Fig. 2. Expression of Gal2 or Gal2QL in the stably transfected cell 
lines. Total RNA were isolated form cells transfected with PGKneo 
(3T3), Gal2 (3T3-12) or Gal2QL (3T3-12QL). After reverse tran- 
scription cDNA was amplified by PCR as descrtbed m section 2. 
foci are generally smaller than those induced by the YL(S 
mutant with the equivalent substitution mutation (glu- 
tamine-61 to leucine) (Fig. 1). Cells transfected with the 
wild type Gal2 or the pCMV vector did not form foci 
(Fig. 1). Gal2QL, in which the residue glutamine- 
was replaced by leucine, is presumably activated, since 
similar mutations in Gas [ 171, Gai2 [ 181, Gal 1, Gclq 
[14] and ras [l] were found to result in constitutively 
active proteins. The mutation probably leads to the at- 
tenuation of GTPase activity, thus fixing the protein in 
the GTP bound or active form. Therefore, the putative 
activated form of Gal2 was able to alter growth charac- 
teristics of NIH3T3 cells. These results are consistent 
with the finding that gene expression of the Gal2 was 
associated with focus formation [1.5]. 
To further investigate the potential involvement of 
Gal2 in transformation and tumorigenesis, we estab- 
lished cell lines stably expressing PGKneo, Gal2 or 
Gal 2QL. designated 3T3-neo, 3T3-12 or 3T3-12QL. 
The expression of Gal 2 or Gal2QL was verified by 
PCR amplification of the cDNA synthesized from RNA 
isolated from these stable cell lines. The expected sizes 
of PCR products were observed for both 3T3-12 and 
3T3-12QL (Fig. 2). However, we were not able to 
clearly detect Gal2 and Gal2QL proteins with a spe- 
cific antibody in these stable cell lines, though Gal2 and 
its mutant proteins could be clearly detected with the 
antibody in COS-7 cells transiently transfected with the 
same expression vectors. This indicates that the expres- 
sion levels of Gal2 and Gal2QL driven by the COS-7 
promoter in NIH3T3 cells are relatively low. 
The stable transfected cell lines were examined by a 
number of standard tests for transformation. Up to 60% 
of 3T3- 12QL cells formed colonies in soft agar, whereas 
non-transfected NIH3T3 cells, 3T3-12 and 3T3-neo 
cells formed few colonies (Table I). In a tumorigenesis 
test, tumors began to show up in all of the seven mice 
injected with 3T3-12QL cells after ten days, but did not 
show up in mice injected with non-transfected cells or 
cells expressing PGKneo or the wild type of Gal2 even 
after 40 days (Table I). The doubling time and satura- 
tion densities of these stable cell lines are not substan- 
tially different (Table I). However, only 3T3-12QL cells 
were able to survive in medium containing 0.1% FCS 
(Table I), even though cell number only doubled after 
six days. The low growth rate may be partially attri- 
buted to the poor attachment in the presence of low 
levels of serum. No live cells of 3T3, 3T3-12 or 3T3-neo 
were found after six days culture in 0.1% FCS. All of 
these results indicate that the activated form of Gal2 
is capable of inducing transformation and tumorigene- 
sis in NIH3T3 cells. 
Aaronson and his co-workers [ 121 reported that over- 
expression of the wild type human Gal2 in NIH3T3 
cells could induce transformation and tumorigenesis. 
However. in our hands, expression of Gal2 driven by 
the CMV promoter was not oncogenic. The inability of 
Gal2 carried by the pCMV vector to transform 
NIH3T3 cells may be due to the low expression level of 
this protein. Gal2 and Gal3 form a class of G proteins 
that is distinguished by amino acid sequence homology 
from all of the other G-proteins. The nature of the 
Table I 
Transformatton of NIH3T3 cells by Gal2QL 
Saturation density” Cell doubhng time” Survival m 0.1% of Growth m soft agar Tumor formatton in 
(x 10’ cells) (h) serumb (%) nude mtced 
3T3 3 24 No 3 o/4 
3T3-neo 6 24 No 3 o/4 
3T3-12 6.4 24 No 4 015 
3T3-12QL 9 20 Yes 60 Ill 
a 2 x lo4 cells were plated m duplicate m each well of 24-well plates. Saturation densittes and cell doubling ttme were determined based on the growth 
curves. 
‘2 x lo4 cells were seeded in duplicate m each well of 24-well plates. The cells was changed to the medium containing 0.1% FCS 5 h after seeding. 
The numbers of cells were counted after 6 days. 
c 150 cells were plated in 0.3% of agar and the colonies contaming more than 20 cells were counted after 17 days. 
d 2 x 10’ cells were injected subcutaneously on the back of nude 
mites. Tumors were observed after 10 days. 
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effector or of the receptors that interact with these ubiq- 
uitously expressed proteins is not known. It is possible 
that they couple to seven pass membrane receptors that 
can control growth by modulating the activity of the 
proteins that control the cell cycle. We have also tested 
transforming activity of the activated form of Gc113 by 
using the focus formation assay and we found that acti- 
vated Gal3 was also capable of inducing focus forma- 
tion of NIH3T3 cells (data not shown). 
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